ALEXANDRIA, Va., June 9 -- United States Patent no. 12,287,324, issued on April 29, was assigned to University of North Texas Health Science Center At Fort Worth (Fort Worth, Texas).

"Companion diagnostics for NSAIDS and donepezil for treating specific subpopulations of patients suffering from Alzheimer's disease" was invented by Sid E. O'Bryant (Aledo, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method for identifying a patient response to treatment for Alzheimer's Disease with a non-steroidal anti-inflammatory drug (NSAID) or an acetylcholinesterase (AChE) inhibitor drug comprising: obtaining a blood or serum sample from the patient; determining the presence of a p...